Reimbursed with a limitationOriginator productATC B02BD04

Refixia

Refixia is an originator product from Novo Nordisk Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 953.55 to CHF 5'516.05 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Novo Nordisk Pharma AG
ATC code
B02BD04
IT group
06.01.10 Blutkonserven und Plasmafraktionen
Active substances
Nonacogum beta pegolum
Preparation type
Originator product
On the SL since
01/11/2017
Last price change
01/12/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Refixia Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 500 IE c Solv1 StkCHF 889.38CHF 953.5501/12/2024B7680662160019
Trockensub 1000 IE c Solv1 StkCHF 1'778.76CHF 1'866.0501/12/2024B7680662160026
Trockensub 2000 IE c Solv1 StkCHF 3'557.52CHF 3'691.0501/12/2024B7680662160033
Trockensub 3000 IE c Solv1 StkCHF 5'336.28CHF 5'516.0501/12/2024B7680662160040

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/05/2014

Preisberechnung für Blutpräparate aufgrund des Fabrikabgabepreises zuzüglich einer Fixmarge wegen der speziellen Verteilersituation (praktisch kein Zwischenhandel) von Fr. 40.-- zuzüglich MWST. Diese Berechnung gilt nicht für die Humanalbumine.

More preparations in this group

FAQ

Is Refixia covered by Swiss health insurance?

Yes, but only under conditions. Refixia is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Refixia cost in Switzerland?

The public price is the maximum price set by the FOPH and for Refixia ranges from CHF 953.55 to CHF 5'516.05 per pack. The ex-factory price ranges from CHF 889.38 to CHF 5'336.28. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com